blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1412353

EP1412353 - IMIDAZOPYRIDINONES AS P38 MAP KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.01.2006
Database last updated on 12.08.2024
Most recent event   Tooltip06.01.2006No opposition filed within time limitpublished on 22.02.2006  [2006/08]
Applicant(s)For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
[2004/18]
Inventor(s)01 / ALONSO-ALIJA, Cristina
August-Macke-Weg 3
42781 Haan / DE
02 / MICHELS, Martin
Nibelungenstr. 65
42653 Solingen / DE
03 / SCHIROK, Hartmut
Glockengiesserweg 13
44329 Dortmund / DE
04 / SCHLEMMER, Karl-Heinz
Wildsteig 22a
42113 Wuppertal / DE
05 / DODD, Sara
11 Capulet Court
Huntingdon, PE29 1PH / GB
06 / FITZGERALD, Mary
2 Paternoster Court, Cassington Road
Yarnton, Oxfordshire OX5 1QB / GB
07 / BELL, John C/O AstraZeneca R&D
Charnwood, Discovery Bioscience, Bakewell Rd.
Loughborough, Leics LE11 5RH / GB
08 / GILL, Andrew
136a Littlebrook Avenue
Burnham, Slough SL2 2NE / GB
 [2004/18]
Application number, filing date02758340.015.07.2002
[2004/18]
WO2002EP07834
Priority number, dateGB2001001750618.07.2001         Original published format: GB 0117506
[2004/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03008413
Date:30.01.2003
Language:EN
[2003/05]
Type: A1 Application with search report 
No.:EP1412353
Date:28.04.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 30.01.2003 takes the place of the publication of the European patent application.
[2004/18]
Type: B1 Patent specification 
No.:EP1412353
Date:02.03.2005
Language:EN
[2005/09]
Search report(s)International search report - published on:EP30.01.2003
ClassificationIPC:C07D471/04, A61K31/437, A61P29/00
[2004/18]
CPC:
C07D471/04 (EP,US); A61P29/00 (EP); A61P43/00 (EP)
Designated contracting statesDE,   ES,   FR,   GB,   IT [2004/36]
Former [2004/18]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:IMIDAZOPYRIDINONE ALS P38 MAP KINASE INHIBITOREN[2004/18]
English:IMIDAZOPYRIDINONES AS P38 MAP KINASE INHIBITORS[2004/18]
French:IMIDAZOPYRIDINONES EN TANT QU'INHIBITEURS DE PROTEINE-KINASE ASSOCIEE AUX MEMBRANES (MAP KINASE) P38[2004/18]
Entry into regional phase18.02.2004National basic fee paid 
18.02.2004Designation fee(s) paid 
18.02.2004Examination fee paid 
Examination procedure22.01.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.02.2004Examination requested  [2004/18]
17.08.2004Communication of intention to grant the patent
27.12.2004Fee for grant paid
27.12.2004Fee for publishing/printing paid
Opposition(s)05.12.2005No opposition filed within time limit [2006/08]
Fees paidRenewal fee
02.08.2004Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]JPS5585595
 [A]  - PATENT ABSTRACTS OF JAPAN, (19800920), vol. 004, no. 135, Database accession no. (C - 025), & JP55085595 A 19800627 (YAMANOUCHI PHARMACEUT CO LTD) [A] 1-14 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.